SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Donnan GA, Fisher M, Macleod M, Davis SM. Stroke. Lancet 2008; 371: 161223.
  • 2
    US Food and Drug Administration. Early communication about an ongoing safety review of tiotropium (marketed as Spiriva HandiHaler). Available at http://www.fda.gov/cder/drug/early_comm/tiotropium.htm (last accessed 20 July 2008).
  • 3
    Spiriva HandiHaler (tiotropium bromide) Summary of Product Characteristics. Boehringer Ingelheim. Available at http://emc.medicines.org.uk/emc/industry/default.asp?page=displaydoc.asp&documentid=10039 (last accessed 20 August 2008).
  • 4
    Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S, Decramer M; UPLIFT Study Investigators. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 154354.
  • 5
    Singh S, Loke YK, Furberg CD. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300: 143950.
  • 6
    Whitaker H. The self controlled case series method. BMJ 2008; 337: a1069.
  • 7
    Grosso A, Douglas I, Hingorani A, MacAllister R, Smeeth L. Post-marketing assessment of the safety of strontium ranelate; a novel case-only approach to the early detection of adverse drug reactions. Br J Clin Pharmacol 2008; 66: 68994.
  • 8
    Douglas IJ, Smeeth L. Exposure to antipsychotics and risk of stroke: self controlled case series study. BMJ 2008; 337: a1227.
  • 9
    Hubbard R, Lewis S, West J, Smith C, Godfrey C, Smeeth L, Farrington P, Britton J. Bupropion and the risk of sudden death: a self-controlled case-series analysis using The Health Improvement Network. Thorax 2005; 60: 84850.
  • 10
    Macie C, Wooldrage K, Manfreda J, Anthonisen N. Cardiovascular morbidity and the use of inhaled bronchodilators. Int J Chron Obstruct Pulmon Dis 2008; 3: 1639.
  • 11
    General practice research database. Available at http://www.gprd.com/home/ (last accessed 25 March 2008).
  • 12
    Farrington CP. Relative incidence estimation from case series for vaccine safety evaluation. Biometrics 1995; 51: 22835.
  • 13
    Powrie DJ, Wilkinson TM, Donaldson GC, Jones P, Scrine K, Viel K, Kesten S, Wedzicha JA. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J 2007; 30: 4728.
  • 14
    Boekholdt SM, Peters RJ, Hack CE, Day NE, Luben R, Bingham SA, Wareham NJ, Reitsma PH, Khaw KT. IL-8 plasma concentrations and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Arterioscler Thromb Vasc Biol 2004; 24: 15038.